The data indicated that activation of GLP-1R alleviated depression-like behaviors and associated neuroinflammation through inhibiting GSDMD-mediated microglial pyroptosis by promoting mitophagy in the depressive hippocampus. Here, GSDMD is linked to depressive symptom measurement.